SynthesisFrontiers in immunology2026
Efficacy and safety of tumor necrosis factor-α inhibitors and mesenchymal stem cells in the treatment of fistulizing Crohn's disease: a systematic review and network meta-analysis.
Xue-Min Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.